Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 16, 2006 - Issue 12
Submit an article Journal homepage
55
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Clopidogrel bisulfate (Plavix®, Sanofi and Bristol-Myers Squibb): another billion dollar drug under attack by the generics

Komal Shah Bhukhanwala CEO, InnovarIP Consulting Group, 3rd Floor, Bhukhanvala Chambers, B-28 Veera Industrial Estate, Andheri West, Mumbai 400 053, India. [email protected]
&
Rca Godbole Senior Associate, InnovarIP Consulting Group, 3rd Floor, Bhukhanvala Chambers, B-28 Veera Industrial Estate, Andheri West, Mumbai 400 053, India. [email protected]
Pages 1609-1611 | Published online: 22 Nov 2006

Bibliography

  • Bristol-Myers and Sanofi aventis v. Apotex
  • ARIENS EJ: Chirality in bioactive agents and its pitfalls. Trends Pharamcol. Sci. (1986) 7:200-205.
  • WALDECK, B: Three-dimensional pharmacology, a subject ranging from ignorance to overstatements. Pharmacol. Toxicol. (2003) 93:203-210.
  • KENAKIN TP: An in vitro quantitative analysis of the α adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity. J. Pharmacol. Exp. Therap. (1981) 216:210-219.
  • AGRANAT I, CANER H: Intellectual Property and chirality of drugs. Drug Discov. Today (1999) 4(7):313-321.
  • Re Dillon (1990) 919 F.2d 68, 16 USPQ 692-693.
  • Forest Laboratories Inc. et al. v. Ivax Pharmaceuticals Inc. et al. (2006) 03-891-JJF D. Del.
  • SMITH D: The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area. Neurosci. Behav. Rev.(1986) 10:37-46.

Patents

Websites

  • http://patentbaristas.com/archives/000252. php Pfizer wins one/loses one in UK patent suit over Lipitor

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.